These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 29844477)

  • 1. Serum metabolite profile associated with incident type 2 diabetes in Koreans: findings from the Korean Genome and Epidemiology Study.
    Yang SJ; Kwak SY; Jo G; Song TJ; Shin MJ
    Sci Rep; 2018 May; 8(1):8207. PubMed ID: 29844477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach.
    Floegel A; Stefan N; Yu Z; Mühlenbruch K; Drogan D; Joost HG; Fritsche A; Häring HU; Hrabě de Angelis M; Peters A; Roden M; Prehn C; Wang-Sattler R; Illig T; Schulze MB; Adamski J; Boeing H; Pischon T
    Diabetes; 2013 Feb; 62(2):639-48. PubMed ID: 23043162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes and branched-chain amino acids: What is the link?
    Bloomgarden Z
    J Diabetes; 2018 May; 10(5):350-352. PubMed ID: 29369529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amino acid and lipid metabolism in post-gestational diabetes and progression to type 2 diabetes: A metabolic profiling study.
    Lai M; Liu Y; Ronnett GV; Wu A; Cox BJ; Dai FF; Röst HL; Gunderson EP; Wheeler MB
    PLoS Med; 2020 May; 17(5):e1003112. PubMed ID: 32433647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-targeted metabolomic biomarkers and metabotypes of type 2 diabetes: A cross-sectional study of PREDIMED trial participants.
    Urpi-Sarda M; Almanza-Aguilera E; Llorach R; Vázquez-Fresno R; Estruch R; Corella D; Sorli JV; Carmona F; Sanchez-Pla A; Salas-Salvadó J; Andres-Lacueva C
    Diabetes Metab; 2019 Apr; 45(2):167-174. PubMed ID: 29555466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma metabolomics identified novel metabolites associated with risk of type 2 diabetes in two prospective cohorts of Chinese adults.
    Qiu G; Zheng Y; Wang H; Sun J; Ma H; Xiao Y; Li Y; Yuan Y; Yang H; Li X; Min X; Zhang C; Xu C; Jiang Y; Zhang X; He M; Yang M; Hu Z; Tang H; Shen H; Hu FB; Pan A; Wu T
    Int J Epidemiol; 2016 Oct; 45(5):1507-1516. PubMed ID: 27694567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific Metabolic Profiles and Their Relationship to Insulin Resistance in Recent-Onset Type 1 and Type 2 Diabetes.
    Knebel B; Strassburger K; Szendroedi J; Kotzka J; Scheer M; Nowotny B; Müssig K; Lehr S; Pacini G; Finner H; Klüppelholz B; Giani G; Al-Hasani H; Roden M;
    J Clin Endocrinol Metab; 2016 May; 101(5):2130-40. PubMed ID: 26829444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolomics Signatures in Type 2 Diabetes: A Systematic Review and Integrative Analysis.
    Sun Y; Gao HY; Fan ZY; He Y; Yan YX
    J Clin Endocrinol Metab; 2020 Apr; 105(4):. PubMed ID: 31782507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in the metabolism of phospholipids, bile acids and branched-chain amino acids predicts development of type 2 diabetes in black South African women: a prospective cohort study.
    Zeng Y; Mtintsilana A; Goedecke JH; Micklesfield LK; Olsson T; Chorell E
    Metabolism; 2019 Jun; 95():57-64. PubMed ID: 30954560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma Acylcarnitines and Risk of Type 2 Diabetes in a Mediterranean Population at High Cardiovascular Risk.
    Guasch-Ferré M; Ruiz-Canela M; Li J; Zheng Y; Bulló M; Wang DD; Toledo E; Clish C; Corella D; Estruch R; Ros E; Fitó M; Arós F; Fiol M; Lapetra J; Serra-Majem L; Liang L; Papandreou C; Dennis C; Martínez-González MA; Hu FB; Salas-Salvadó J
    J Clin Endocrinol Metab; 2019 May; 104(5):1508-1519. PubMed ID: 30423132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Untargeted metabolic profiling identifies altered serum metabolites of type 2 diabetes mellitus in a prospective, nested case control study.
    Drogan D; Dunn WB; Lin W; Buijsse B; Schulze MB; Langenberg C; Brown M; Floegel A; Dietrich S; Rolandsson O; Wedge DC; Goodacre R; Forouhi NG; Sharp SJ; Spranger J; Wareham NJ; Boeing H
    Clin Chem; 2015 Mar; 61(3):487-97. PubMed ID: 25524438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations of cardiac stress biomarkers with incident type 2 diabetes and changes in glucose metabolism: KORA F4/FF4 study.
    Sujana C; Seissler J; Jordan J; Rathmann W; Koenig W; Roden M; Mansmann U; Herder C; Peters A; Thorand B; Then C
    Cardiovasc Diabetol; 2020 Oct; 19(1):178. PubMed ID: 33066780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No Interaction with Alcohol Consumption, but Independent Effect of C12orf51 (HECTD4) on Type 2 Diabetes Mellitus in Korean Adults Aged 40-69 Years: The KoGES_Ansan and Ansung Study.
    Kim J; Oh B; Lim JE; Kim MK
    PLoS One; 2016; 11(2):e0149321. PubMed ID: 26891264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Habitual late sleep initiation is associated with increased incidence of type 2 diabetes mellitus in Korean adults: the Korean Genome and Epidemiology Study.
    Seo JA; Lee DY; Yu JH; Cho H; Lee SK; Suh S; Kim SG; Choi KM; Baik SH; Shin C; Kim NH
    Sleep; 2019 Jul; 42(7):. PubMed ID: 30994171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolite ratios as potential biomarkers for type 2 diabetes: a DIRECT study.
    Molnos S; Wahl S; Haid M; Eekhoff EMW; Pool R; Floegel A; Deelen J; Much D; Prehn C; Breier M; Draisma HH; van Leeuwen N; Simonis-Bik AMC; Jonsson A; Willemsen G; Bernigau W; Wang-Sattler R; Suhre K; Peters A; Thorand B; Herder C; Rathmann W; Roden M; Gieger C; Kramer MHH; van Heemst D; Pedersen HK; Gudmundsdottir V; Schulze MB; Pischon T; de Geus EJC; Boeing H; Boomsma DI; Ziegler AG; Slagboom PE; Hummel S; Beekman M; Grallert H; Brunak S; McCarthy MI; Gupta R; Pearson ER; Adamski J; 't Hart LM
    Diabetologia; 2018 Jan; 61(1):117-129. PubMed ID: 28936587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarkers for predicting type 2 diabetes development-Can metabolomics improve on existing biomarkers?
    Savolainen O; Fagerberg B; Vendelbo Lind M; Sandberg AS; Ross AB; Bergström G
    PLoS One; 2017; 12(7):e0177738. PubMed ID: 28692646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycolysis/gluconeogenesis- and tricarboxylic acid cycle-related metabolites, Mediterranean diet, and type 2 diabetes.
    Guasch-Ferré M; Santos JL; Martínez-González MA; Clish CB; Razquin C; Wang D; Liang L; Li J; Dennis C; Corella D; Muñoz-Bravo C; Romaguera D; Estruch R; Santos-Lozano JM; Castañer O; Alonso-Gómez A; Serra-Majem L; Ros E; Canudas S; Asensio EM; Fitó M; Pierce K; Martínez JA; Salas-Salvadó J; Toledo E; Hu FB; Ruiz-Canela M
    Am J Clin Nutr; 2020 Apr; 111(4):835-844. PubMed ID: 32060497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum amino acid profiles and risk of type 2 diabetes among Japanese adults in the Hitachi Health Study.
    Chen S; Akter S; Kuwahara K; Matsushita Y; Nakagawa T; Konishi M; Honda T; Yamamoto S; Hayashi T; Noda M; Mizoue T
    Sci Rep; 2019 May; 9(1):7010. PubMed ID: 31065046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum metabolomic profile of incident diabetes.
    Rebholz CM; Yu B; Zheng Z; Chang P; Tin A; Köttgen A; Wagenknecht LE; Coresh J; Boerwinkle E; Selvin E
    Diabetologia; 2018 May; 61(5):1046-1054. PubMed ID: 29556673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolite Profiles of Incident Diabetes and Heterogeneity of Treatment Effect in the Diabetes Prevention Program.
    Chen ZZ; Liu J; Morningstar J; Heckman-Stoddard BM; Lee CG; Dagogo-Jack S; Ferguson JF; Hamman RF; Knowler WC; Mather KJ; Perreault L; Florez JC; Wang TJ; Clish C; Temprosa M; Gerszten RE;
    Diabetes; 2019 Dec; 68(12):2337-2349. PubMed ID: 31582408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.